Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
22.74
+0.04 (0.18%)
May 8, 2026, 3:00 PM CST
SHA:600332 Market Cap
SHA:600332 has a market cap or net worth of 35.13 billion as of May 8, 2026. Its market cap has decreased by -9.40% in one year.
Market Cap
35.13B
Enterprise Value
43.58B
Revenue
78.46B
Ranking
n/a
PE Ratio
12.53
Stock Price
22.74
Market Cap Chart
Since February 6, 2001, SHA:600332's market cap has increased from 3.73B to 35.13B, an increase of 842.41%. That is a compound annual growth rate of 9.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 35.13B | -11.48% |
| Dec 31, 2025 | 39.69B | -9.21% |
| Dec 31, 2024 | 43.72B | -1.87% |
| Dec 29, 2023 | 44.55B | -3.89% |
| Dec 30, 2022 | 46.36B | -11.03% |
| Dec 31, 2021 | 52.10B | 16.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Pharmaceuticals Holding | 57.50B |
| Jointown Pharmaceutical Group | 25.23B |
| China National Medicines Corporation | 21.56B |
| Liaoning Cheng Da | 18.24B |
| China Meheco Group | 15.51B |
| Qingdao Baheal Medical INC. | 13.10B |
| China National Accord Medicines Corporation | 12.76B |
| C.Q. Pharmaceutical Holding | 10.14B |